Monthly Archives: March 2025

Capricor Therapeutics to Present at Leerink’s Global Healthcare Conference 2025

SAN DIEGO, March 07, 2025 (GLOBE NEWSWIRE) — Capricor Therapeutics (NASDAQ:CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics for the treatment of rare diseases, today announced that Capricor management will participate in one-on-one investor meetings and provide a corporate update at Leerink’s Global Healthcare Conference 2025, taking place …

Read More »